If you liked this article you might like

Amgen Osteoporosis Drug Approval Plan Derailed Over Heart Safety Risk -- Jim Cramer Weighs In
Biotech Movers: Radius Health, Amgen, Paratek
Wake Up Wall Street: Political Upheaval Surrounding President Trump Shows No Sign of Abating
UCB Stock Plunges After Trials Reveal Safety Risk in Amgen JV